KENDRA ALEXANDER: Open Payments
NPI 1003441460 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 30 payments from 8 companies in 2025. Trend: 2023 $835 · 2024 $564 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $226 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| PFIZER INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| IBSA Pharma Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: NURTEC ODT, FARXIGA, TRINTELLIX, MOUNJARO, Ozempic, Saxenda, Wegovy, Tirosint.
Industry payments across TX — which companies pay providers there.
